Login / Signup

The upper-airway microbiota and loss of asthma control among asthmatic children.

Yanjiao ZhouDaniel JacksonLeonard B BacharierDavid MaugerHomer BousheyMario CastroJuliana DurackYvonne HuangRobert F LemanskeGregory A StorchGeorge M WeinstockKristine WylieRonina CovarAnne M FitzpatrickWanda PhipatanakulRachel G RobisonAvraham Beigelman
Published in: Nature communications (2019)
The airway microbiome has an important role in asthma pathophysiology. However, little is known on the relationships between the airway microbiome of asthmatic children, loss of asthma control, and severe exacerbations. Here we report that the microbiota's dynamic patterns and compositions are related to asthma exacerbations. We collected nasal blow samples (n = 319) longitudinally during a clinical trial at 2 time-points within one year: randomization when asthma is under control, and at time of early loss of asthma control (yellow zone (YZ)). We report that participants whose microbiota was dominated by the commensal Corynebacterium + Dolosigranulum cluster at RD experience the lowest rates of YZs (p = 0.005) and have longer time to develop at least 2 episodes of YZ (p = 0.03). The airway microbiota have changed from randomization to YZ. A switch from the Corynebacterium + Dolosigranulum cluster at randomization to the Moraxella- cluster at YZ poses the highest risk of severe asthma exacerbation (p = 0.04). Corynebacterium's relative abundance at YZ is inversely associated with severe exacerbation (p = 0.002).
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • cystic fibrosis
  • allergic rhinitis
  • clinical trial
  • young adults
  • randomized controlled trial
  • early onset
  • double blind
  • phase iii